Impact of CKD Progression on Cardiovascular Disease Risk in a Contemporary UK Cohort of Individuals With Diabetes

Impact of CKD Progression on Cardiovascular Disease Risk in a Contemporary UK Cohort of Individuals With Diabetes

Introduction: It remains unclear whether an increased progression rate of chronic kidney disease (CKD) adds predictive information regarding cardiovascular disease (CVD) risk. The aim of this study was to evaluate the association between CKD progression, based on estimated glomerular filtration rate...

Full description

Bibliographic Details
Main Authors:	Claudia S. Cabrera, Alison S. Lee, Marita Olsson, Volker Schnecke, Klara Westman, Marcus Lind, Peter J. Greasley, Stanko Skrtic
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	Kidney International Reports
Subjects:	chronic kidney disease diabetes epidemiology heart disease hypertension statistical
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024920314285

Similar Items

FGF23 and Phosphate–Cardiovascular Toxins in CKD
by: Isabel Vogt, et al.
Published: (2019-11-01)

The Protective Role of Klotho in CKD-Associated Cardiovascular Disease
by: Xianjin Bi, et al.
Published: (2020-08-01)

Management of Hypertension in CAKUT: Protective Factor for CKD
by: Marina M. Gabriele, et al.
Published: (2019-06-01)

The Preserving Kidney Function in Children With CKD (PRESERVE) Study: Rationale, Design, and Methods
by: Michelle R. Denburg, et al.
Published: (2023-11-01)

CKD and CKDu in northern Peru: a cross-sectional analysis under the DEGREE protocol
by: Andrea Ruiz-Alejos, et al.
Published: (2021-01-01)

Isolated Diastolic Hypertension and Kidney and Cardiovascular Outcomes in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study
by: Saud Al Saleh, et al.
Published: (2023-12-01)

Rationale and design of a multicenter Chronic Kidney Disease (CKD) and at-risk for CKD electronic health records-based registry: CURE-CKD
by: Keith C. Norris, et al.
Published: (2019-11-01)

Copeptin, Natriuretic Peptides, and Cardiovascular Outcomes in Patients With CKD: The German Chronic Kidney Disease (GCKD) Study
by: Markus P. Schneider, et al.
Published: (2023-11-01)

Deoxycholic Acid and Risks of Cardiovascular Events, ESKD, and Mortality in CKD: The CRIC StudyPlain-Language Summary
by: Rebecca Frazier, et al.
Published: (2022-01-01)

Disparity of serum uric acid threshold for CKD among hypertensive and non-hypertensive individuals
by: Bowen Zhu, et al.
Published: (2024-12-01)

Protein Biomarkers and Major Cardiovascular Events in Older People With Advanced CKD: The European Quality (EQUAL) Study
by: Samantha J.L. Hayward, et al.
Published: (2024-01-01)

CKD-Associated Pruritus and Clinical Outcomes in Nondialysis CKD
by: Jennifer S. Scherer, et al.
Published: (2024-01-01)

Editorial: Biomarkers in CKD
by: Magali Araujo, et al.
Published: (2017-10-01)

The Role of Inflammation in CKD
by: Saurav Prashant Kadatane, et al.
Published: (2023-06-01)

Effect of chronic kidney disease on the association between hyperuricemia and new‐onset hypertension in the general Japanese population: ISSA‐CKD study
by: Miki Kawazoe, et al.
Published: (2021-12-01)

The Prevalence of Potential Drug-Drug Interactions in CKD-A Retrospective Observational Study of Cerrahpasa Nephrology Unit
by: Andleeb Shahzadi, et al.
Published: (2022-01-01)

An economic evaluation of intensive hypertension control in CKD patients: a cost-effectiveness study
by: Ye Seol Lee, et al.
Published: (2022-11-01)

Effects of a high-phosphorus diet on the gut microbiota in CKD rats
by: Guoxin Ye, et al.
Published: (2021-01-01)

The link between chronic kidney disease and cardiovascular disease
by: Sarmad Said, et al.
Published: (2014-07-01)

The association between blood albumin level and cardiovascular complications and mortality risk in ICU patients with CKD
by: Fengming Huang, et al.
Published: (2022-07-01)

Urinary angiotensinogen antedates the development of stage 3 CKD in patients with type 1 diabetes mellitus
by: Sheeba Ba Aqeel, et al.
Published: (2019-10-01)

Temporal trajectories of important diseases in the life course and premature mortality in the UK Biobank
by: Xianwen Shang, et al.
Published: (2022-05-01)

The Role of Physical Activity in the CKD Setting
by: Filippo Aucella, et al.
Published: (2014-07-01)

Association of Zinc Deficiency with Development of CVD Events in Patients with CKD
by: Shinya Nakatani, et al.
Published: (2021-05-01)

Importance and repercussions of renal and cardiovascular pathology on stroke in young adults: an anatomopathologic study of 52 clinical necropsies
by: Gabriel Arismendi-Morillo, et al.
Published: (2008-01-01)

Empagliflozin in Adults with Chronic Kidney Disease (CKD): Current Evidence and Place in Therapy
by: Colbert GB, et al.
Published: (2023-02-01)

Trends in using of antihypertensive medication among US CKD adults, NHANES 2001–2018
by: Fanghua Li, et al.
Published: (2023-02-01)

Atherosclerosis Specific Features in Chronic Kidney Disease (CKD)
by: Anastasia V. Poznyak, et al.
Published: (2022-08-01)

Plasma Serotonin and Cardiovascular Outcomes in Chronic Kidney Disease
by: Daniel Edmonston, et al.
Published: (2023-09-01)

Hyperphosphatemia Drives Procoagulant Microvesicle Generation in the Rat Partial Nephrectomy Model of CKD
by: Nima Abbasian, et al.
Published: (2020-11-01)

Are Alterations in DNA Methylation Related to CKD Development?
by: Jacek Rysz, et al.
Published: (2022-06-01)

Pediatric Acute Kidney Injury to the Subsequent CKD Transition
by: Fang Wang, et al.
Published: (2020-11-01)

CKD-Associated Cardiovascular Mortality in the United States: Temporal Trends From 1999 to 2020Plain-Language Summary
by: Ofer Kobo, et al.
Published: (2023-03-01)

Prognostic Significance of ABPM in Comparison to Clinical Blood Pressure Monitoring and their Association with Various Risk Factors Involved in CKD Predisposition in North Indian Patients
by: seema singh, et al.
Published: (2021-12-01)

Masked CKD in hyperthyroidism and reversible CKD status in hypothyroidism
by: Natsumi Uchiyama-Matsuoka, et al.
Published: (2022-11-01)

Innate Immunity and CKD: Is There a Significant Association?
by: Moran Plonsky-Toder, et al.
Published: (2023-11-01)

Hyperuricemia; a warning sign of future cardiovascular events and chronic kidney disease
by: Farahnak Assadi
Published: (2018-01-01)

Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA‐CKD Trial
by: Glenn M. Chertow, et al.
Published: (2023-05-01)

A quantitative analysis of chronic exposure of selected heavy metals in a model diet in a CKD hotspot in Sri Lanka
by: T. B. Ananda Jayalal, et al.
Published: (2019-06-01)

Gait characteristics of CKD patients: a systematic review
by: Damiano D. Zemp, et al.
Published: (2019-03-01)